1116116-97-2

Upstream product

• 1116116-96-1 5-chloro-2-isopropyl-6-phenyl[1,2,4]triazolo[1,5-a]pyrimidine 
• 87199-17-5 4-formylphenylboronic acid, 

Downstream Products

• 1240468-00-1 2-isopropyl-6-phenyl-5-(4-{3-[5-(pyridine-2-yl)-1H-[1,2,4]triazole-3-yl]-azetidine-1-ylmethyl}-phenyl)-[1,2,4]triazolo[1,5-a]pyrimidine 
• 1116116-93-8 2-isopropyl-6-phenyl-5-(4-{[4-(5-pyridin-2-yl-1H-1,2,4-triazol-3-yl)piperidin-1-yl]methyl}phenyl)[1,2,4]triazolo[1,5-a]pyrimidine 

Relevant academic research and scientific papers

FUSED PYRIMIDINES

Compounds of formula (I), or an N-oxide, a salt, a tautomer or a stereoisomer of said compound, or a salt of said N-oxide, tautomer or stereoisomer, wherein ring B and the pyrimidine to which it is fused, R4, R5, R6, R7, m and n have the meanings as given in the description and the claims, which are effective inhibitors of the Pi3K/Akt pathway, processes for their production and their use as pharmaceuticals.

FUSED BICYCLIC PYRIMIDINES

Compounds of formula (I), a tautomer or stereoisomer thereof, or a salt thereof, wherein ring B and the pyrimidine to which it is fused, R4, R5, R6 and R7 have the meanings as given in the description and the claims, are effective inhibitors of the Pi3K/Akt pathway.

FUSED BICYCLIC PYRIMIDINES

Compounds of formula (I) a tautomer or stereoisomer thereof, or a salt thereof, wherein ring B and the pyrimidine to which it is fused, R4, R5, R6 and R7 have the meanings as given in the description and the claims, are effective inhibitors of the Pi3K/Akt pathway.